1. Home
  2. Analysis
  3. Varenicline-tartrate
  4. Micardis

Varenicline tartrate and Micardis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 7 people who take Varenicline tartrate and Micardis. Common interactions include nausea among females, and abnormal behaviour among males.

The phase IV clinical study analyzes what interactions people who take Varenicline tartrate and Micardis have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

7 people who take Varenicline tartrate and Micardis together, and have interactions are studied.

What is Varenicline tartrate?

Varenicline tartrate has active ingredients of varenicline tartrate. Currently, eHealthMe is studying from 3,587 Varenicline tartrate users.

What is Micardis?

Micardis has active ingredients of telmisartan. It is used in high blood pressure. Currently, eHealthMe is studying from 27,259 Micardis users.

Number of Varenicline tartrate and Micardis reports submitted per year:

Varenicline tartrate and Micardis drug interactions.

Common Varenicline Tartrate and Micardis drug interactions by gender *:

female:

  1. Nausea
  2. Abnormal dreams
  3. Anxiety
  4. Asthenia
  5. Bedridden
  6. Fatigue
  7. Increased appetite
  8. Irritability
  9. Labyrinthitis
  10. Nightmare

male:

  1. Abnormal behaviour
  2. Decreased appetite
  3. Hyperhidrosis
  4. Delirium
  5. Dizziness
  6. Loss of consciousness
  7. Road traffic accident
  8. Drug eruption
  9. Amnesia
  10. Confusional state

Common Varenicline Tartrate and Micardis drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Drug eruption

60+:

  1. Nausea
  2. Abnormal behaviour
  3. Increased appetite
  4. Irritability
  5. Labyrinthitis
  6. Loss of consciousness
  7. Nightmare
  8. Pain in extremity
  9. Road traffic accident
  10. Sensation of heaviness

* Approximation only. Some reports may have incomplete information.

Do you take Varenicline tartrate and Micardis?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Varenicline tartrate drug interactions:

Browse interactions between Varenicline tartrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Micardis drug interactions:

Browse interactions between Micardis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on varenicline tartrate and telmisartan (the active ingredients of Varenicline tartrate and Micardis, respectively), and Varenicline tartrate and Micardis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Varenicline tartrate and Micardis.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.